| Home | E-Submission | Sitemap | Editorial Office |  
top_img
Clinical and Molecular Hepatology Search > Browse Articles > Search



Efficacy and safety of entecavir versus lamivudine over 5 years of treatment: A randomized controlled trial in Korean patients with hepatitis B e antigen-negative chronic hepatitis B
Kwan Sik Lee, Young-Oh Kweon, Soon-Ho Um, Byung-Ho Kim, Young Suk Lim, Seung Woon Paik, Jeong Heo, Heon-Ju Lee, Dong Joon Kim, Tae Hun Kim, Young-Sok Lee, Kwan Soo Byun, Daeghon Kim, Myung Seok Lee, Kyungha Yu, Dong Jin Suh
Clin Mol Hepatol.2017;23(4):331-339.   Published online September 26, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0040
                                 Cited By 2
Clinical characteristics of patients with chronic hepatitis B who developed genotypic resistance to entecavir: Real-life experience
Hong Joo Kim, Yong Kyun Cho, Woo Kyu Jeon, Byung Ik Kim
Clin Mol Hepatol.2017;23(4):323-330.   Published online September 5, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0005
                                 Cited By 3
Lamivudine: fading into the mists of time
Jonggi Choi, Young-Suk Lim
Clin Mol Hepatol.2017;23(4):314-315.   Published online November 28, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0110
                              
Is it possible to predict the development of an entecavir resistance mutation in patients with chronic hepatitis B in clinical practice?
Joon Yeul Nam, Jeong-Hoon Lee
Clin Mol Hepatol.2017;23(4):311-313.   Published online December 4, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0069
                              
Efficacy of tenofovir-based rescue therapy for chronic hepatitis B patients with resistance to lamivudine and entecavir
Hee-Jeong Jeon, Seok Won Jung, Neung Hwa Park, Yujin Yang, Jin-Hee Noh, Jae-Sung Ahn, Hyung Rae Kim, Jae Ho Lee, Jung Woo Shin
Clin Mol Hepatol.2017;23(3):230-238.   Published online June 30, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0003
                                 Cited By 4
Is tenofovir monotherapy a sufficient defense line against multi-drug resistant hepatitis B virus?
Yun Bin Lee, Jeong-Hoon Lee
Clin Mol Hepatol.2017;23(3):219-221.   Published online September 19, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0045
                              
Comparison of the clinical outcomes between antiviral-naïve patients treated with entecavir and lamivudine-resistant patients receiving adefovir add-on lamivudine combination treatment
Hong Joo Kim, Soo Kyung Park, Hyo Joon Yang, Yoon Suk Jung, Jung Ho Park, Dong Il Park, Yong Kyun Cho, Chong Il Sohn, Woo Kyu Jeon, Byung Ik Kim, Kyu Yong Choi
Clin Mol Hepatol.2016;22(3):350-358.   Published online September 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0019
                              
The efficacy of tenofovir-based therapy in patients showing suboptimal response to entecavir-adefovir combination therapy
Jeong Han Kim, Sung Hyun Ahn, Soon Young Ko, Won Hyeok Choe, Kyun-Hwan Kim, So Young Kwon
Clin Mol Hepatol.2016;22(2):241-249.   Published online June 15, 2016     
DOI: https://doi.org/10.3350/cmh.2015.0053
                                 Cited By 3
Regression of esophageal varices during entecavir treatment in patients with hepatitis-B-virus-related liver cirrhosis
Hye Young Jwa, Yoo-Kyung Cho, Eun Kwang Choi, Heung Up Kim, Hyun Joo Song, Soo-Young Na, Sun-Jin Boo, Seung Uk Jeong, Bong Soo Kim, Byoung-Wook Lee, Byung-Cheol Song
Clin Mol Hepatol.2016;22(1):183-187.   Published online March 28, 2016     
DOI: https://doi.org/10.3350/cmh.2016.22.1.183
                                 Cited By 3
Entecavir plus tenofovir versus entecavir plus adefovir in chronic hepatitis B patients with a suboptimal response to lamivudine and adefovir combination therapy
Jung Gil Park, Soo Young Park
Clin Mol Hepatol.2015;21(3):242-248.   Published online September 30, 2015     
DOI: https://doi.org/10.3350/cmh.2015.21.3.242
                                 Cited By 1
Impact of prior lamivudine use on the antiviral efficacy and development of resistance to entecavir in chronic hepatitis B patients
Joo An Hwang, Kee Bum Kim, Min Jae Yang, Sun Gyo Lim, Jae Chul Hwang, Jae Youn Cheong, Sung Won Cho, Soon Sun Kim
Clin Mol Hepatol.2015;21(2):131-140.   Published online June 26, 2015     
DOI: https://doi.org/10.3350/cmh.2015.21.2.131
                                 Cited By 2
Efficacy of prolonged entecavir monotherapy in treatment-naïve chronic hepatitis B patients exhibiting a partial virologic response to entecavir
Han Na Choi, Jeong Eun Song, Hyeon Chul Lee, Hyeong Ho Jo, Chang Hyeong Lee, Byung Seok Kim
Clin Mol Hepatol.2015;21(1):24-31.   Published online March 25, 2015     
DOI: https://doi.org/10.3350/cmh.2015.21.1.24
                                 Cited By 10
Long-term outcomes of two rescue therapies in lamivudine-refractory patients with chronic hepatitis B: combined lamivudine and adefovir, and 1-mg entecavir
EunYoung Ze, Eun Kyung Baek, Jong Jin Lee, Han Wook Chung, Dae Geon Ahn, Hwan Jun Cho, Jae Cheol Kwon, Hyung Joon Kim, HyunWoong Lee
Clin Mol Hepatol.2014;20(3):267-273.   Published online September 25, 2014     
DOI: https://doi.org/10.3350/cmh.2014.20.3.267
                                 Cited By 5
HBsAg level and clinical course in patients with chronic hepatitis B treated with nucleoside analogue: five years of follow-up data
Jeong Han Kim, Yun Jung Choi, Hee Won Moon, Soon Young Ko, Won Hyeok Choe, So Young Kwon
Clin Mol Hepatol.2013;19(4):409-416.   Published online December 28, 2013     
DOI: https://doi.org/10.3350/cmh.2013.19.4.409
                                 Cited By 4
Performance evaluation of the HepB Typer-Entecavir kit for detection of entecavir resistance mutations in chronic hepatitis B
Sang Hoon Ahn, Ji-Yong Chun, Soo-Kyung Shin, Jun Yong Park, Wangdon Yoo, Sun Pyo Hong, Soo-Ok Kim, Kwang-Hyub Han
Clin Mol Hepatol.2013;19(4):399-408.   Published online December 28, 2013     
DOI: https://doi.org/10.3350/cmh.2013.19.4.399
                              Supplementary      
Efficacy and safety of entecavir plus carnitine complex (GODEX®) compared to entecavir monotherapy in patient with ALT elevated chronic hepatitis B: randomized, multicenter open-label trials. The GOAL study
Dae Won Jun, Byung Ik Kim, Yong Kyun Cho, Hong Ju Kim, Young Oh Kwon, Soo Young Park, Sang Young Han, Yang Hyun Baek, Yong Jin Jung, Hwi Young Kim, Won Kim, Jeong Heo, Hyun Young Woo, Seong Gyu Hwang, Kyu Sung Rim, Jong Young Choi, Si Hyun Bae, Young Sang Lee, Young Suck Lim, Jae Youn Cheong, Sung Won Cho, Byung Seok Lee, Seok Hyun Kim, Joo Hyun Sohn, Tae Yeob Kim, Yong Han Paik, Ja Kyung Kim, Kwan Sik Lee
Clin Mol Hepatol.2013;19(2):165-172.   Published online June 27, 2013     
DOI: https://doi.org/10.3350/cmh.2013.19.2.165
                                 Cited By 9
Antiviral efficacies of currently available rescue therapies for multidrug-resistant chronic hepatitis B
Mi Sung Park, Beom Kyung Kim, Kyung Sik Kim, Ja Kyung Kim, Seung Up Kim, Jun Yong Park, Do Young Kim, Oidov Baartarkhuu, Kwang Hyub Han, Chae Yoon Chon, Sang Hoon Ahn
Clin Mol Hepatol.2013;19(1):29-35.   Published online March 25, 2013     
DOI: https://doi.org/10.3350/cmh.2013.19.1.29
                                 Cited By 9
Clinical impacts of hazardous alcohol use and obesity on the outcome of entecavir therapy in treatment-naïve patients with chronic hepatitis B infection
Won Gil Chung, Hong Joo Kim, Young Gil Choe, Hyo Sun Seok, Chang Wook Chon, Yong Kyun Cho, Byung Ik Kim, Young Yool Koh
Clin Mol Hepatol.2012;18(2):195-202.   Published online June 26, 2012     
DOI: https://doi.org/10.3350/cmh.2012.18.2.195
                                 Cited By 6
High efficacy of adefovir and entecavir combination therapy in patients with nucleoside-refractory hepatitis B
Hee Bok Chae, Mee Jin Kim, Eui Geun Seo, Yong Hyeok Choi, Hee Seung Lee, Joung Ho Han, Soon Man Yoon, Seon Mee Park, Sei Jin Youn
Korean J Hepatol.2012;18(1):75-83.   Published online March 22, 2012     
DOI: https://doi.org/10.3350/kjhep.2012.18.1.75
                                 Cited By 11
Pretreatment serum HBsAg-to-HBV DNA ratio predicts a virologic response to entecavir in chronic hepatitis B
Joon Chang Song, Bo Young Min, Jin-Wook Kim, Jong Yeop Kim, Yeo Myeong Kim, Cheol Min Shin, Sang Hyub Lee, Jin-Hyeok Hwang, Sook-Hyang Jeong, Nayoung Kim, Dong Ho Lee
Korean J Hepatol.2011;17(4):268-273.   Published online December 26, 2011     
DOI: https://doi.org/10.3350/kjhep.2011.17.4.268
                                 Cited By 5
Genotypic resistance to entecavir in chronic hepatitis B patients
Byeong Uk Kim, M.D., Ja Chung Goo, M.D., Byeong Chul Park, M.D., Soo Ok Kim, Ph.D.1, Sun Pyo Hong, Ph.D.1, Jee In Jeong, M.D., Hee Bok Chae, M.D., Seon Mee Park, M.D., Sei Jin Youn, M.D.
Korean J Hepatol.2010;16(2):147-157.   Published online June 25, 2010     
DOI: https://doi.org/10.3350/kjhep.2010.16.2.147
         Cited By 2
Efficacy and predictors of the virologic response to entecavir therapy in nucleoside naive patients with chronic hepatitis B
Hyung-Joon Myung, M.D., Sook-Hyang Jeong, M.D., Jin-Wook Kim, M.D., Hee-Sup Kim, M.D., Je-Hyuck Jang, M.D., Dong Ho Lee, M.D., Nayoung Kim, M.D., Jin-Hyeok Hwang, M.D., Young Soo Park, M.D., Sang-Hyub Lee, M.D.
Korean J Hepatol.2010;16(1):57-65.   Published online March 26, 2010     
DOI: https://doi.org/10.3350/kjhep.2010.16.1.57
         Cited By 8
Validity and reliability of the nonalcoholic fatty Liver diseases activity score (NAS) in Korean NAFLD patients and its correlation with clinical factors
Kyung-Hun Lee, M.D., Sang Hoon Park, M.D., Yu Jin Kim, M.D., Kyung Rim Huh, M.D., Kwang Seon Min1, M.D., Sun-Young Jun1, M.D., Kyoung Oh Kim, M.D., Cheol Hee Park, M.D., Taeho Hahn, M.D., Kyo-Sang Yoo, M.D., Jong Hyeok Kim, M.D., Myung-Seok Lee, M.D., Choong Kee Park, M.D.
Korean J Hepatol.2010;16(1):29-37.   Published online March 26, 2010     
DOI: https://doi.org/10.3350/kjhep.2010.16.1.29
         Cited By 1
Predictors for virologic response in management of chronic hepatitis B
Jung Min Lee, M.D.1, Sang Hoon Ahn, M.D.1-3
Korean J Hepatol.2010;16(1):1-4.   Published online March 26, 2010     
DOI: https://doi.org/10.3350/kjhep.2010.16.1.1
      
Clinical efficacy of entecavir therapy and factors associated with treatment response in naive chronic hepatitis B patients
Myoung Hee Lee , Sun Gyo Lim , Su Jin Jeon , Chang Joon Kang , Young Ju Cho , Soon Sun Kim , Da Mi Lee , Jae Youn Cheong , Sung Won Cho
Korean J Hepatol.2009;15(4):446-453.   Published online December 31, 2009     
DOI: https://doi.org/10.3350/kjhep.2009.15.4.446
         Cited By 4
The Korean Journal of Entecavir 1 mg therapy for Lamivudine-refractory chronic hepatitis B
Hyung Joon Kim
Korean J Hepatol.2008;14(3):411-416.   Published online September 30, 2008     
DOI: https://doi.org/10.3350/kjhep.2008.14.3.411
      
1 |
E-Submission
Email Alert
Author's Index
EndNote Style file download
The Korean Association for the Study of the Liver
The Liver Week 2019
SCImago Journal & Country Rank
PubMed Central
PubMed
Scopus
KoreaMed
KoMCI
ScienceCentral
DOAJ
GoogleScholar
Similarity Check
Crossref Cited-by Linking
CrossMark
Funder Registry
ORCID
MeSH on Demand
COPE
Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © The Korean Association for the Study of the Liver. All rights reserved.         
COUNTER
TODAY : 161
TOTAL : 212961